FTSE All-Share
4 986,34
|
-9,01
|
-0,18 %
|
Analysen zu FTSE All-Share-Werten
16.01.24 | BP Underweight | JP Morgan Chase & Co. | |
16.01.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
16.01.24 | GSK Buy | Jefferies & Company Inc. | |
16.01.24 | Rio Tinto Neutral | UBS AG | |
16.01.24 | AstraZeneca Sell | UBS AG | |
15.01.24 | GSK Buy | UBS AG | |
15.01.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
15.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
15.01.24 | Unilever Sell | UBS AG | |
15.01.24 | National Grid Buy | Deutsche Bank AG | |
15.01.24 | Vodafone Group Neutral | JP Morgan Chase & Co. | |
12.01.24 | Vodafone Group Equal Weight | Barclays Capital | |
12.01.24 | Glencore Equal Weight | Barclays Capital | |
12.01.24 | Rio Tinto Overweight | Barclays Capital | |
12.01.24 | Glencore Buy | Goldman Sachs Group Inc. | |
12.01.24 | Rio Tinto Buy | Goldman Sachs Group Inc. | |
11.01.24 | Glencore Buy | Deutsche Bank AG | |
11.01.24 | Rio Tinto Buy | Deutsche Bank AG | |
10.01.24 | Diageo Underperform | RBC Capital Markets | |
10.01.24 | BAT Neutral | JP Morgan Chase & Co. | |
10.01.24 | Unilever Underweight | JP Morgan Chase & Co. | |
10.01.24 | GSK Buy | Deutsche Bank AG | |
10.01.24 | Diageo Neutral | JP Morgan Chase & Co. | |
09.01.24 | GSK Equal Weight | Barclays Capital | |
09.01.24 | GSK Equal Weight | Barclays Capital | |
09.01.24 | GSK Sell | UBS AG | |
09.01.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
08.01.24 | Shell Overweight | JP Morgan Chase & Co. | |
08.01.24 | Diageo Outperform | Bernstein Research | |
08.01.24 | Shell Outperform | RBC Capital Markets | |
08.01.24 | Rio Tinto Neutral | UBS AG | |
08.01.24 | Shell Buy | Jefferies & Company Inc. | |
08.01.24 | Shell Overweight | Barclays Capital | |
08.01.24 | Shell Buy | UBS AG | |
08.01.24 | HSBC Holdings Buy | Jefferies & Company Inc. | |
05.01.24 | GSK Underweight | JP Morgan Chase & Co. | |
05.01.24 | AstraZeneca Hold | Deutsche Bank AG | |
04.01.24 | BP Overweight | Barclays Capital | |
04.01.24 | Shell Overweight | Barclays Capital | |
04.01.24 | BP Outperform | RBC Capital Markets |